مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

960
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

DOES TREATMENT OF HYPERTHYROIDISM AFFECT SERUM LIPIDS, LIPOPROTEINS AND PARAOXONASE ENZYME ACTIVITY?

Pages

  233-238

Abstract

 Thyroid hormones play an important role in the synthesis, metabolism, and catabolism of lipids. Hyperthyroid patients have increased susceptibility to oxidative stresses and thus undergo LDL oxidation. PARAOXONASE is an HDL-linked enzyme which, in vitro, prevents LDL oxidation and might have an anti-atherogenic effect. The purpose of this study was to compare PARAOXONASE activity and lipid status before and after treatment of HYPERTHYROIDISM. 24 hyperthyroid patients and 23 control subjects were studied. In all subjects after obtaining history and anthropometric measurements, serum levels of thyroid hormones, lipids, LIPOPROTEINs, and APOLIPOPROTEINs and serum PARAOXONASE activity were measured in a fasting blood sample. All patients were treated with METHIMAZOLE and followed up for 7.3±3.9 months. Of 24 patients, 15 attained euthyroidism. There were no significant changes in weight, body mass index, and waist to hip ratio after treatment. There was significant decrease in serum levels of T4 (8.4±2.2 vs. 16.6±4.4 µg/dL, P<0.001), T3 (134±38 vs. 250±90 ng/dL, P<0.05), and increase in serum TSH (1.9±2.2 vs. 0.06±0.06 µU/mL, P<0.001). Serum PARAOXONASE activity significantly increased after treatment (49.0±22.8 vs. 64.6±37.8 IU/mL, P<0.001). Also, treatment caused significant increase in serum cholesterol, triglycerides, LDL-C, cholesterol to HDL and LDL to HDL ratios. HDL and APOLIPOPROTEINs A-I and B levels did not change following treatment. The observed changes in serum PARAOXONASE activity in the present study, suggest that the enhanced oxidation observed in these patients can be, at least to some extent, caused by reduced PARAOXONASE activity.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    SOULATI, M., RAEISZADEH, F., ETEMADI, A., & AZIZI, F.. (2002). DOES TREATMENT OF HYPERTHYROIDISM AFFECT SERUM LIPIDS, LIPOPROTEINS AND PARAOXONASE ENZYME ACTIVITY? . IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM), 3(4 (SN 12)), 233-238. SID. https://sid.ir/paper/27739/en

    Vancouver: Copy

    SOULATI M., RAEISZADEH F., ETEMADI A., AZIZI F.. DOES TREATMENT OF HYPERTHYROIDISM AFFECT SERUM LIPIDS, LIPOPROTEINS AND PARAOXONASE ENZYME ACTIVITY? . IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM)[Internet]. 2002;3(4 (SN 12)):233-238. Available from: https://sid.ir/paper/27739/en

    IEEE: Copy

    M. SOULATI, F. RAEISZADEH, A. ETEMADI, and F. AZIZI, “DOES TREATMENT OF HYPERTHYROIDISM AFFECT SERUM LIPIDS, LIPOPROTEINS AND PARAOXONASE ENZYME ACTIVITY? ,” IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM), vol. 3, no. 4 (SN 12), pp. 233–238, 2002, [Online]. Available: https://sid.ir/paper/27739/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button